Vilaseca J, Tor J, Puig Costa M, Ribera A, Martín C, Guardia J
Med Clin (Barc). 1980 Jul 15;75(3):126-8.
A 27-year-old male developed an autoimmune hemolytic anemia during the initial episode of chronic ulcerative colitis. Laboratory studies revealed a positive direct Coomb's test (IgG + C), and the presence of specific anti-Hr antibody. Salicylazosulfapyridine was tested by means of immunohematologic techniques, but results discarded this drug as the responsible agent for autoimmune hemolytic anemia. Association of ulcerative colitis and autoimmune hemolytic anemia is an uncommon finding; around 36 cases have been published in the literature. Hemolytic anemia may develop as a consequence of treatment with salicylazosulfapyridine, the antimicrobial of choice in the management of inflammatory diseases of the bowel.
一名27岁男性在慢性溃疡性结肠炎首发期间发生了自身免疫性溶血性贫血。实验室检查显示直接抗人球蛋白试验阳性(IgG + C),且存在特异性抗-Hr抗体。通过免疫血液学技术对柳氮磺胺吡啶进行了检测,但结果排除了该药物是自身免疫性溶血性贫血的致病因素。溃疡性结肠炎与自身免疫性溶血性贫血的关联是一种罕见的发现;文献中已发表了约36例相关病例。溶血性贫血可能是肠道炎症性疾病治疗中首选抗菌药物柳氮磺胺吡啶治疗的结果。